Medical Marijuana Inc. (MJNA)

MJNA Inc.’s CEO, Dr. Stuart Titus, called into to provide the listening audience with his personal insights into the Company’s recent news regarding their efforts in Brazil, their help with the path to legalization in Puerto Rico, the validation for the Company’s top cannabis products from one of top cannabis testing lab, ProVerde Labs. In addition, Dr. Titus gave a comprehensive progress report on the efforts of AXIM. Recently MJNA announced that they hold 14,943,650 shares of common stock and 500,000 shares of preferred stock in AXIM Biotechnologies (AXIM), a cutting-edge biotechnology innovator.

This interview may include forward looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this release. Although the Company believes that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof.